SCHEMBL659162

SCHEMBL659162

Brc1sc2cnccc2c1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.40
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
NCOA1 Q15788 2/20 0.38
NCOA3 Q9Y6Q9 2/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RCE1 Q9Y256 1/20 0.38
AXL P30530 1/20 0.37
CYP2A6 P11509 4/20 0.34
CHUK O15111 3/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PRKD3 O94806 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660127 0.80 KDM4E (0.40) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL11885002 0.77 KDM4E (0.44) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL660301 0.76 HTT (0.38) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL658563 0.74 ALDH1A1 (0.49) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL657642 0.74 BRAF (0.42) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL660147 0.73 KDM4E (0.51) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL16238134 0.70 ALDH1A1 (0.70) KDM4EALDH1A1HTTNCOA1NCOA3
SCHEMBL11884987 0.70 KDM4E (0.40) KDM4EALDH1A1HTTNCOA1NCOA3
SCHEMBL16693332 0.69 CHUK (0.51) IMPDH2KDM4EALDH1A1HTTNCOA1
SCHEMBL309376 0.69 GPR3 (0.55) KDM4EALDH1A1HPGDGAACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 IMPDH2 408/4885KDM4E 117/4885ALDH1A1 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.